Activation of human intraepithelial lymphocytes reduces CD3 expression

E C Ebert1

  • 1Department of Medicine, UMDNJ-Robert Wood Johnson Medical School, New Brunswick, NJ, USA.

Insights

Human intraepithelial lymphocytes (IELs) show reduced activation compared to peripheral blood (PB) T cells. This impaired response, seen with phytohaemagglutinin (PHA) and CD3 ligation, affects calcium influx and CD3 expression.

Area of Science:

  • Immunology
  • Gastroenterology
  • Cell Biology

Background:

  • Human intraepithelial lymphocytes (IELs) play a crucial role in gut immunity.
  • IELs exhibit distinct functional properties compared to peripheral blood (PB) lymphocytes.
  • Previous studies suggest IELs have limited responses to common T-cell activation stimuli.

Purpose of the Study:

  • To investigate the functional capacity of human IELs in response to phytohaemagglutinin (PHA) and CD3 ligation.
  • To compare the activation pathways of IELs with CD8+ T cells from peripheral blood.
  • To elucidate the molecular mechanisms underlying IEL hyporesponsiveness.

Main Methods:

  • Isolation of IELs from jejunal mucosa and PB lymphocytes.
  • Analysis of calcium influx using Fura-2.
  • Measurement of IL-2 receptor expression via immunofluorescence and flow cytometry.
  • Quantification of IL-2 production using ELISA.
  • Detection of apoptosis using Apo 2.7 staining.

Main Results:

  • IELs exhibited transient and low-amplitude calcium influx upon CD3 ligation and PHA stimulation, respectively.
  • IL-2 receptor expression was reduced post-CD3 ligation but normal after PHA stimulation.
  • Both IELs and PB lymphocytes produced similar IL-2 amounts.
  • CD3 expression declined on activated IELs, unlike PB CD8+ T cells, due to incomplete reexpression.

Conclusions:

  • Human IELs demonstrate partial activation in response to PHA and CD3 ligation.
  • Diminished calcium influx and altered CD3 expression contribute to IEL hyporesponsiveness.
  • These findings highlight unique activation characteristics of IELs in the intestinal immune system.